SCHEMBL2783169

SCHEMBL2783169

Nc1cc2c(N)ccc(C(O)(C(F)(F)F)C(F)(F)F)c2cc1C(O)(C(F)(F)F)C(F)(F)F

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SMN1; SMN2 Q16637 2/20 0.54
▸ MEN1 O00255 3/20 0.47
▸ KMT2A Q03164 3/20 0.47
▸ KDM4E B2RXH2 2/20 0.47
▸ MAPT P10636 2/20 0.47
▸ HSD17B10 Q99714 2/20 0.47
▸ ALDH1A1 P00352 1/20 0.47
▸ GLA P06280 1/20 0.47
▸ POLB P06746 1/20 0.47
▸ GAA P10253 1/20 0.47
▸ HPGD P15428 1/20 0.47
▸ ATM Q13315 1/20 0.47
▸ MAPK1 P28482 2/20 0.45
▸ LMNA P02545 1/20 0.45
▸ HTT P42858 1/20 0.45
▸ NPSR1 Q6W5P4 1/20 0.45
▸ KCNJ11 Q14654 15/20 0.36
▸ ABCC9 O60706 7/20 0.35
▸ ABCC8 Q09428 7/20 0.35
▸ KCNJ8 Q15842 7/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2784209 1.00 SMN1; SMN2 (0.54) SMN1; SMN2MEN1KMT2AKDM4EMAPT
SCHEMBL2784727 0.91 SMN1; SMN2 (0.55) SMN1; SMN2MEN1KMT2AKDM4EMAPT
SCHEMBL2784631 0.88 SMN1; SMN2 (0.50) SMN1; SMN2MEN1KMT2AKDM4EMAPT
SCHEMBL2783264 0.88 SMN1; SMN2 (0.50) SMN1; SMN2MEN1KMT2AKDM4EMAPT
SCHEMBL2785182 0.82 SMN1; SMN2 (0.47) SMN1; SMN2MEN1KMT2AKDM4EMAPT
SCHEMBL2784641 0.82 SMN1; SMN2 (0.50) SMN1; SMN2MEN1KMT2AKDM4EMAPT
SCHEMBL2783771 0.81 SMN1; SMN2 (0.53) SMN1; SMN2MEN1KMT2AKDM4EMAPT
SCHEMBL2782291 0.81 SMN1; SMN2 (0.53) SMN1; SMN2MEN1KMT2AKDM4EMAPT
SCHEMBL2784079 0.81 MEN1 (0.61) SMN1; SMN2MEN1KMT2AKDM4EMAPT
SCHEMBL2785174 0.81 SMN1; SMN2 (0.49) SMN1; SMN2MEN1KMT2AKDM4EMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130085237-A1 Fluorinated Diamine and Polymer Formed Therefrom CENTRAL GLASS COMPANY, LIMITED (JP) 2013-04-04 — — US disclosed
US-20100029895-A1 Fluorinated Diamine and Polymer Formed Therefrom CENTRAL GLASS COMPANY, LIMITED (JP) 2010-02-04 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100029895-A1 Fluorinated Diamine and Polymer Formed Therefrom AFF2, AFF1, AFF4 SMN1; SMN2 3673/4885MEN1 2546/4885KMT2A 662/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback